CANGENE CORPORATION

ACCRETROPIN

HUMAN GROWTH HORMONE;

ACROTROPIN

HUMAN GROWTH HORMONE;

ANTI-SARS

Therapeutic Pharmaceutical Preparations for the Treatment of Respiratory Illness;ANTI SARS;

CANGENE

GENETIC ENGINEERING EXPRESSION EQUIPMENT, NAMELY, BIOLOGICAL EXPRESSION EQUIPMENT FOR EXPRESSING PROPRIETARY AND CUSTOMER GENES;LABORATORY EQUIPMENT, NAMELY, BIOLOGICAL EXPRESSIONS APPARATUS FOR EXPRESSING PROPRIETARY AND CUSTOMER GENES IN E. COLI AND IN YEAST;MEDICAL DIAGNOSTIC EQUIPMENT, NAMELY, NUCLEIC ACID SEQUENCE BASE AMPLIFICATION FOR DIAGNOSTIC USE AND NUCLEIC ACID BASED TESTING EQUIPMENT FOR THE DIAGNOSIS OF CLINICAL INFECTIONS;

CANGENE

RESEARCH, CONSULTING AND CONTRACT WORK RELATING TO GENETIC ENGINEERING, BIOTECHNOLOGY AND BIOPHARMACEUTICALS;

CANGENE BIOPHARMA

Contract manufacturing in the field of biopharmaceutical products;The mark consists of the word CANGENE in white lettering, in a blue rectangle with white lines above and below the rectangle; the word BIOPHARMA in black lettering appears below the rectangle and a blue arc appears below this word.;The color(s) blue, black and white is/are claimed as a feature of the mark.;Wholesale pharmaceutical supply services and distributorship services in the field of biopharmaceutical products;BIOPHARMA;

CANGENE PLASMA RESOURCES

The mark consists of the wording CANGENE PLASMA RESOURCES in grey with entwined tubes in the colors blue, grey and yellow.;The color(s) grey, blue and yellow is/are claimed as a feature of the mark.;Plasma services, namely, blood plasma collection;PLASMA AND RESOURCES;